Understanding the Decline of HIV Incidence: Insights from Structural Equation Modeling of Social and Biological Factors

Abstract

Aim: Nigeria ranks among the countries with a high burden of Human Immunodeficiency Virus (HIV), though national incidence and prevalence have declined in recent years. Ekiti State has consistently shown lower HIV rates compared to other regions, but the specific drivers of this perceived decline remain underexplored. This study aimed to identify the key social, behavioral, and biological factors contributing to the declining HIV incidence in Ekiti State, Nigeria, using Structural Equation Modelling (SEM).
Material and Methods: A cross-sectional survey was conducted from January to March 2023 among 448 knowledgeable informants (health professionals from state and local AIDS control agencies, medical personnel, and students). Data on perceived HIV incidence and contributing factors were collected via a structured questionnaire. Confirmatory Factor Analysis and SEM were performed using AMOS software to test hypothesized paths from latent constructs (social factors, e.g., condom promotion and education campaigns; sexual behavioral factors, e.g., reductions in concurrent partners; biological factors, e.g., antiretroviral therapy access and STI reductions) to perceived declining incidence.
Results: Social (β = 0.356, p < 0.001) and biological (β = 0.309, p < 0.001) factors were significantly associated with perceived decline in HIV incidence, while sexual behavioral factors were not (β = 0.019, p > 0.05). The model demonstrated good fit (CFI = 0.987, RMSEA = 0.030, χ²/df = 1.389).
Conclusion: The perceived reduction in HIV incidence in Ekiti State is primarily associated with social and biological interventions. These findings highlight the value of integrated public health approaches and support efforts toward Sustainable Development Goal 3 (Good health and well-being).

Keywords

• Human immunodeficiency virüs
• structural equation modeling
• perceived decline
• social factors
• biological factors
• good health and well-being

References

1. 1. Joint United Nations Programme on HIV/AIDS (UNAIDS). Nigeria country data [Internet]. 2024 [cited 2025 Dec 25]. Available from: https://www.unaids.org/en/regionscountries/countries/nigeria
2. 2. Joint United Nations Programme on HIV/AIDS (UNAIDS). Key results in Nigeria [Internet]. 2024 [cited 2025 Dec 25]. Available from: https://open.unaids.org/countries/nigeria
3. 3. Ekiti State Action Committee on AIDS. HIV/AIDS Ekiti state strategic plan for action (2010-2015). 2009. Unpublished document obtained from the Ekiti State Aids Control Agency.
4. 4. Ekiti State Action Committee on AIDS. Ekiti state HIV and AIDS strategic plan for action (2021-2025). 2021. Unpublished document obtained from the Ekiti State Aids Control Agency.
5. 5. Salihu HM, Murtala HA, Murtala AM, Abdullahi AA, Abbas MA, Yusuf AL, et al. HIV‐tuberculosis co‐infection in conflict zones of Nigeria. Trop Med Int Health. 2025;30(7):625-32. doi:10.1111/tmi.14112.
6. 6. Ali MJ, Onoja A, Shambe I, Afolaranmi T, Egbere OJ, Olorunfemi PO, et al. Prevalence of human immunodeficiency virus and selected sexually transmitted infections among female sex workers in Jos, Nigeria. Journal of Epidemiological Society of Nigeria. 2025;8(1-2):46-57. doi:10.5281/zenodo.16889829.
7. 7. Ukaegbu E, Alibekova R, Ali S, Crape B, Issanov A. Trends of HIV/AIDS knowledge and attitudes among Nigerian women between 2007 and 2017 using Multiple Indicator Cluster Survey data. BMC Public Health. 2022;22(1):440. doi:10.1186/s12889-022-12865-y.
8. 8. Joint United Nations Programme on HIV/AIDS. HIV and AIDS in Nigeria: 2018 UNAIDS statistics for Nigeria [Internet]. 2019 [cited 2025 December 25]. Available from: https://www.avert.org/professionals/hiv-around-world/sub-saharan-africa/nigeria

9. 9. Vandormael A, Cuadros D, Dobra A, Bärnighausen T, Tanser F. HIV incidence declines in a rural South African population: a G-imputation approach for inference. BMC Public Health. 2020;20(1):1205. doi:10.1186/s12889-020-09193-4.
10. 10. Kagaayi J, Chang LW, Ssempijja V, Grabowski MK, Ssekubugu R, Nakigozi G, et al. Impact of combination HIV interventions on HIV incidence in hyperendemic fishing communities in Uganda: a prospective cohort study. Lancet HIV. 2019;6(10):e680-7. doi:10.1016/S2352-3018(19)30190-0.
11. 11. Makhema J, Wirth KE, Pretorius Holme M, Gaolathe T, Mmalane M, Kadima E, et al. Universal testing, expanded treatment, and incidence of HIV infection in Botswana. N Engl J Med. 2019;381(3):230-42. doi:10.1056/NEJMoa1812281.
12. 12. Pettifor A, MacPhail C, Hughes JP, Selin A, Wang J, Gómez-Olivé FX, et al. The effect of a conditional cash transfer on HIV incidence in young women in rural South Africa (HPTN 068): a phase 3, randomised controlled trial. Lancet Glob Health. 2016;4(12):e978-88. doi:10.1016/S2214-109X(16)30253-4.
13. 13. Borgdorff MW, Kwaro D, Obor D, Otieno G, Kamire V, Odongo F, et al. HIV incidence in western Kenya during scale-up of antiretroviral therapy and voluntary medical male circumcision: a population-based cohort analysis. Lancet HIV. 2018;5(5):e241-9. doi:10.1016/S2352-3018(18)30025-0.
14. 14. Chen Y, Li AD, Yang Y, Lu J, Xu Y, Ji X, et al. Global, regional and national burden of HIV/AIDS among individuals aged 15-79 from 1990 to 2021. AIDS Res Ther. 2025;22(1):51. doi:10.1186/s12981-025-00745-5.
15. 15. U.S. Centers for Disease Control and Prevention. HIV declines among young people and drives overall decrease in new HIV infections [Internet]. 2023 [cited 2025 December 26]. Available from: https://www.cdc.gov/media/releases/2023/p0523-hiv-declines-among-young-people.html
16. 16. Grabowski MK, Serwadda DM, Gray RH, Nakigozi G, Kigozi G, Kagaayi J, et al. HIV prevention efforts and incidence of HIV in Uganda. N Engl J Med. 2017;377(22):2154-66. doi:10.1056/NEJMoa1702150.
17. 17. Grilo SA, Thompson J, Chen IS, Nalugoda F, Lutalo T, Wei Y, et al. Declines in HIV incidence and prevalence and predictors among adolescents and young adults: an observational cohort study, Rakai, Uganda, 2005-2020. medRxiv [Preprint]. 2025; 2025.01.07.25320118. doi:10.1101/2025.01.07.25320118.
18. 18. Mhlanga L, Welte A, Grebe E, Ohler L, van Cutsem G, Huerga H, et al. Evidence of HIV incidence reduction in young women, but not in adolescent girls, in KwaZulu-Natal, South Africa. IJID Reg. 2023;8:111-7. doi:10.1016/j.ijregi.2023.07.004.
19. 19. Hayes RJ, Donnell D, Floyd S, Mandla N, Bwalya J, Sabapathy K, et al. Effect of universal testing and treatment on HIV incidence—HPTN 071 (PopART). N Engl J Med. 2019;381(3):207-18. doi:10.1056/NEJMoa1814556.
20. 20. McClelland RS, Richardson BA, Cherutich P, Mandaliya K, John-Stewart G, Miregwa B, et al. A 15-year study of the impact of community antiretroviral therapy coverage on HIV incidence in Kenyan female sex workers. AIDS. 2015;29(17):2279-86. doi:10.1097/QAD.0000000000000829.
21. 21. UNAIDS. Understanding measures of progress towards the 95–95–95 HIV testing, treatment and viral suppression targets [Internet]. 2023 [cited 2025 December 23]. Available from: https://www.unaids.org/sites/default/files/media_asset/progress-towards-95-95-95_en.pdf
22. 22. Jones J, Sullivan PS, Curran JW. Progress in the HIV epidemic: Identifying goals and measuring success. PLoS Med. 2019;16(1):e1002729. doi:10.1371/journal.pmed.1002729.
23. 23. Alamer A. Structural equation modeling (SEM) in L2 writing research: simple tutorial and useful recommendations. Research Methods in Applied Linguistics. 2025;4(2):100202. doi:10.1016/j.rmal.2025.100202.
24. 24. Hargreaves JR, Delany-Moretlwe S, Hallett TB, Johnson S, Kapiga S, Bhattacharjee P, et al. The HIV prevention cascade: integrating theories of epidemiological, behavioural, and social science into programme design and monitoring. Lancet HIV. 2016;3(7):e318-22. doi:10.1016/S2352-3018(16)30063-7.
25. 25. Cochran WG. Sampling techniques. 3rd ed. New York: John Wiley & Sons; 1977.
26. 26. Daniel WW, Cross CL. Biostatistics: a foundation for analysis in the health sciences. 11th ed. New York: John Wiley & Sons; 2018.
27. 27. Hair Jr JF, Black WC, Babin BJ, Anderson RE. Multivariate data analysis. 7th ed. New Jersey: Prentice Hall; 2011.
28. 28. Kline, RB. Principles and practice of structural equation modeling. 3rd ed. New York: The Guilford Press; 2011.
29. 29. Whittle R, Mansell G, Jellema P, van der Windt D. Applying causal mediation methods to clinical trial data: what can we learn about why our interventions (don't) work? Eur J Pain. 2017;21(4):614-22. doi:10.1002/ejp.964.
30. 30. Tabachnick BG, Fidell LS. Using multivariate statistics. 5th ed. New York: Allyn & Bacon/Pearson Education; 2007.
31. 31. Pervan M, Curak M, Pavic Kramaric T. The influence of industry characteristics and dynamic capabilities on firms’ profitability. Int J Financial Stud. 2018;6(1):4. doi:10.3390/ijfs6010004.
32. 32. Fornell C, Larcker DF. Evaluating structural equation models with unobservable variables and measurement error. Journal of Marketing Research. 1981;18(1):39-50. doi:10.2307/3151312.
33. 33. Loverock A, Benny C, Smith BT, Siddiqi A, Pabayo R. Income inequality and deaths of despair risk in Canada, identifying possible mechanisms. Soc Sci Med. 2024;344:116623. doi:10.1016/j.socscimed.2024.116623.
34. 34. Byrne, BM. Structural equation modelling with AMOS: basic concepts, applications, and programming. 3rd ed. New York: Routledge; 2016.
35. 35. Gefen D, Straub D, Boudreau MC. Structural equation modeling and regression: guidelines for research practice. Communications of the Association for Information Systtems. 2000;4(1):7. doi:10.17705/1CAIS.00407.
36. 36. Lei PW, Wu Q. Introduction to structural equation modeling: Issues and practical considerations. Educational Measurement: Issues and Practice. 2007;26(3):33-43. doi:10.1111/j.1745-3992.2007.00099.x.
37. 37. Koropp C, Kellermanns FW, Grichnik D, Stanley L. Financial decision making in family firms: an adaptation of the theory of planned behavior. Family Business Review. 2014;27(4):307-27. doi:10.1177/0894486514522.
38. 38. Hu LT, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Structural Equation Modeling. 1999;6(1):1-55. doi:10.1080/10705519909540118.
39. 39. Kajubi P, Kamya MR, Kamya S, Chen S, McFarland W, Hearst N. Increasing condom use without reducing HIV risk: results of a controlled community trial in Uganda. J Acquir Immune Defic Syndr. 2005;40(1):77-82. doi:10.1097/01.qai.0000157391.63127.b2.
40. 40. Moreno R, Nababan HY, Ota E, Wariki WM, Ezoe S, Gilmour S, et al. Structural and community‐level interventions for increasing condom use to prevent the transmission of HIV and other sexually transmitted infections. Cochrane Database Syst Rev. 2014;2014(7):CD003363. doi:10.1002/14651858.CD003363.pub3.
41. 41. Wariki WM, Ota E, Mori R, Koyanagi A, Hori N, Shibuya K. Behavioral interventions to reduce the transmission of HIV infection among sex workers and their clients in low‐and middle‐income countries. Cochrane Database Syst Rev. 2012;2012(2):CD005272. doi:10.1002/14651858.CD005272.pub3.
42. 42. Kang Dufour MS, Maiorana A, Allen C, Kassie N, Thomas M, Myers J. How faith based organizations’ doctrines regarding sexuality affect their participation in the public health response to HIV in the Eastern Caribbean. Sex Res Soc Policy. 2013;10(3):221-32. doi:10.1007/s13178-013-0123-8.
43. 43. Lv BY, Xiang YX, Zhao R, Feng ZC, Liang SY, Wang YM. Impact evaluation of HIV/AIDS education in rural Henan province of China. J Huazhong Univ Sci Technolog Med Sci. 2013;33(6):905-11. doi:10.1007/s11596-013-1220-x.
44. 44. Faust L, Yaya S. The effect of HIV educational interventions on HIV-related knowledge, condom use, and HIV incidence in sub-Saharan Africa: a systematic review and meta-analysis. BMC Public Health. 2018;18(1):1254. doi:10.1186/s12889-018-6178-y.
45. 45. Maduakolam IO, Ogbonnaya NP, Ndubuisi IF, Ekechukwu EN, Okoronkwoa IL, Onwujekwe O. Effects of a structured health education on prevention of HIV risky behaviours among adolescents in Nigeria–a pragmatic randomized controlled trial. Libyan J. Med. 2022;17(1):2128414. doi:10.1080/19932820.2022.2128414.
46. 46. Kalichman SC, Eaton L, Cherry C. Sexually transmitted infections and infectiousness beliefs among people living with HIV/AIDS: implications for HIV treatment as prevention. HIV Med. 2010: 11(8):502-9. doi:10.1111/j.1468-1293.2009.00818.x.
47. 47. Stead M, Angus K, Langley T, Katikireddi SV, Hinds K, Hilton S, et al. Mass media to communicate public health messages in six health topic areas: a systematic review and other reviews of the evidence. Public Health Res. 2019;7(8). doi:10.3310/phr07080.
48. 48. Decker MR, Crago AL, Chu SK, Sherman SG, Seshu MS, Buthelezi K, et al. Human rights violations against sex workers: burden and effect on HIV. Lancet. 2015;385(9963):186-99. doi:10.1016/S0140-6736(14)60800-X.
49. 49. Watts CH, Foss AM, Hossain M, Zimmerman C, von Simson R, Klot J. Sexual violence and conflict in Africa: prevalence and potential impact on HIV incidence. Sex Trans infections. 2010;86(Suppl 3):iii93-9. doi:10.1136/sti.2010.044610.
50. 50. Shannon K, Strathdee SA, Goldenberg SM, Duff P, Mwangi P, Rusakova M, et al. Global epidemiology of HIV among female sex workers: influence of structural determinants. Lancet. 2015;385(9962):55-71. doi:10.1016/S0140-6736(14)60931-4.
51. 51. Giannou FK, Tsiara CG, Nikolopoulos GK, Talias M, Benetou V, Kantzanou M, et al. Condom effectiveness in reducing heterosexual HIV transmission: a systematic review and meta-analysis of studies on HIV serodiscordant couples. Expert Rev Pharmacoecon Outcomes Res. 2016;16(4):489-99. doi:10.1586/14737167.2016.1102635.
52. 52. Maheu-Giroux M, Vesga JF, Diabaté S, Alary M, Baral S, Diouf D, et al. Changing dynamics of HIV transmission in Cote d'Ivoire: modeling who acquired and transmitted infections and estimating the impact of past HIV interventions (1976–2015). J Acquir Immune Defic Syndr. 2017;75(5):517-27. doi:10.1097/QAI.0000000000001434.
53. 53. Mukandavire Z, Mitchell KM, Vickerman P. Comparing the impact of increasing condom use or HIV pre-exposure prophylaxis (PrEP) use among female sex workers. Epidemics. 2016;14:62-70. doi:10.1016/j.epidem.2015.10.002.
54. 54. Williams JR, Alary M, Lowndes CM, Béhanzin L, Labbé AC, Anagonou S, et al. Positive impact of increases in condom use among female sex workers and clients in a medium HIV prevalence epidemic: modelling results from Project SIDA1/2/3 in Cotonou, Benin. PLoS One. 2014;9(7):e102643. doi:10.1371/journal.pone.0102643.
55. 55. Stover J, Teng Y. The impact of condom use on the HIV epidemic. Gates Open Res. 2022;5:91. doi:10.12688/gatesopenres.13278.
56. 56. Smith MK, Miller WC, Liu H, Ning C, He W, Cohen MS, et al. Effects of patient load and travel distance on HIV transmission in rural China: Implications for treatment as prevention. PloS One. 2017;12(5):e0177976. doi:10.1371/journal.pone.0177976.
57. 57. Ng BE, Butler LM, Horvath T, Rutherford GW. Population‐based biomedical sexually transmitted infection control interventions for reducing HIV infection. Cochrane Database Syst Rev. 2011;(3):CD001220. doi:10.1002/14651858.CD001220.pub3.
58. 58. Cepeda JA, Eritsyan K, Vickerman P, Lyubimova A, Shegay M, Odinokova V, et al. Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling study. Lancet HIV. 2018;5(10):e578-87. doi:10.1016/S2352-3018(18)30168-1.
59. 59. McCree DH, Jeffries WL 4th, Beer L, Gant Z, Elmore K, Sutton M. Exploring factors associated with declining HIV diagnoses among African American females. J Racial Ethn Health Disparities. 2018;5(3):598-604. doi:10.1007/s40615-017-0405-6.
60. 60. Sparviero S, Ragnedda M. Towards digital sustainability: the long journey to the sustainable development goals 2030. Digital Policy, Regulation and Governance. 2021;23(3):216-28. doi:10.1108/DPRG-01-2021-0015.
61. 61. Alhassan GN, Bosnak AS, Hamurtekin E. Perceived satisfaction and outcomes from drug information center services provided with a telehealth approach. Niger J Clin Pract. 2022;25(12):2053-61. doi:10.4103/njcp.njcp_552_22.
62. 62. Abernethy A, Adams L, Barrett M, Bechtel C, Brennan P, Butte A, et al. The promise of digital health: then, now, and the future. NAM Perspect. 2022;2022: 10.31478/202206e. doi:10.31478/202206e.